Department of Biomedical Engineering, Texas A&M University, College Station, TX, 77845, USA.
Department of Biomedical Engineering, Michigan Technological University, Houghton, MI, 49931, USA.
Adv Healthc Mater. 2021 Mar;10(6):e2001537. doi: 10.1002/adhm.202001537. Epub 2021 Jan 27.
Secondary lymphedema is a life-long disorder characterized by chronic tissue swelling and inflammation that obstruct interstitial fluid circulation and immune cell trafficking. Regenerating lymphatic vasculatures using various strategies represents a promising treatment for lymphedema. Growth factor injection and gene delivery have been developed to stimulate lymphangiogenesis and augment interstitial fluid resorption. Using bioengineered materials as growth factor delivery vehicles allows for a more precisely targeted lymphangiogenic activation within the injured site. The implantation of prevascularized lymphatic tissue also promotes in situ lymphatic capillary network formation. The engineering of larger scale lymphatic tissues, including lymphatic collecting vessels and lymph nodes constructed by bioengineered scaffolds or decellularized animal tissues, offers alternatives to reconnecting damaged lymphatic vessels and restoring lymph circulation. These approaches provide lymphatic vascular grafting materials to reimpose lymphatic continuity across the site of injury, without creating secondary injuries at donor sites. The present work reviews molecular mechanisms mediating lymphatic system development, approaches to promoting lymphatic network regeneration, and strategies for engineering lymphatic tissues, including lymphatic capillaries, collecting vessels, and nodes. Challenges of advanced translational applications are also discussed.
继发性淋巴水肿是一种终身性疾病,其特征为慢性组织肿胀和炎症,阻碍了间质液循环和免疫细胞运输。使用各种策略再生淋巴管系统是淋巴水肿治疗的一种有前途的方法。生长因子注射和基因传递已被开发用于刺激淋巴管生成并增加间质液吸收。使用生物工程材料作为生长因子输送载体,可以更精确地在损伤部位激活淋巴管生成。预先血管化的淋巴组织的植入也促进了原位淋巴毛细血管网络的形成。更大规模的淋巴组织的工程,包括通过生物工程支架或去细胞化动物组织构建的淋巴管收集管和淋巴结,为重新连接受损淋巴管和恢复淋巴循环提供了替代方案。这些方法提供了淋巴血管移植物材料,以重新建立损伤部位的淋巴连续性,而不会在供体部位造成二次损伤。本综述讨论了介导淋巴系统发育的分子机制、促进淋巴网络再生的方法以及工程化淋巴组织(包括淋巴管、收集管和淋巴结)的策略。还讨论了高级转化应用的挑战。